Avala 50mg (10 Tablet / Pack)
A low-dose oral PDE5 inhibitor designed for targeted erectile dysfunction management.
Avala 50mg (10 Tablet / Pack) is a lower-strength initiation or maintenance dose of a highly selective phosphodiesterase type 5 (PDE5) inhibitor designed to restore erectile function. It offers a favorable pharmacokinetic profile with rapid absorption, allowing for predictable therapeutic efficacy while significantly minimizing the incidence of dose-dependent adverse reactions.
Purpose
Blocks the PDE5 enzyme to sustain cGMP levels, promoting arterial smooth muscle relaxation and localized blood inflow.
Ingredients
Avanafil 50mg
Warnings
Never take more than one single tablet within a strict 24-hour window, as excessive dosing enhances toxic cardiovascular risks. Contraindicated in individuals who have suffered a recent myocardial infarction, stroke, or severe life-threatening cardiac arrhythmia. Co-administration with strong CYP3A4 inhibitors (like ketoconazole or clarithromycin) requires a mandatory downward dosage adjustment. Stop the medication instantly and report to a physician if you experience a sudden, unexplained loss of hearing or vision.
Side Effects
Mild, temporary facial flushing or a sensation of localized warmth. Light headache, slight dizziness, or mild postural hypotension. Minor back pain, generalized myalgia, or skeletal muscle discomfort. Occasional mild indigestion or low-grade nausea post-ingestion.
Storage Instructions
Store below 25°C in a secure, dry space, entirely protected from direct solar radiation.
| Status | Active |